This drug work by obstructing cells from preparing harmful proteins, which can lead to maladies varying from cancer to HIV,to Ebola. Just a number of these synthetic DNA drugs are on the souk, but a few of them are in clinical trials, comprising a probable treatment for ALS, also called as Lou Gehrig’s ailment.
Drugs crafted from synthetic DNA are customized to capture onto such mutant messenger RNA molecules, linking to them and safeguarding them from whipping out toxic proteins. However, a severe limitation with synthetic DNA is that is can become wimpy. Sometimes it releases its grip, making the messenger RNA free to resume back to its dirty tasks.
Conclusion – The novel procedure has other benefits. It is secured, cost-effective, making it suitable for crafting life-saving drugs. Also, it involves a novel tool to biochemists and microbiologists, who could utilize the method to develop synthetic DNA with an entire assortment of novel properties. A detailed research study of this work is published in the ‘Synthesis of Oligodeoxynucleotides Comprising Electrophilic Groups.’ The other associated authors of this study are Fang, a Ph.D. student Shahien Shahsavari, postdoctoral scientists Deepti Goyal and Jinsen Chen and all the members of Technological Department of Chemistry.
Filed Under: News